Titre : Xanthènes

Xanthènes : Questions médicales fréquentes

Termes MeSH sélectionnés :

Communication
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Xanthènes : Questions médicales les plus fréquentes", "headline": "Xanthènes : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Xanthènes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-07", "dateModified": "2025-05-02", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Xanthènes" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Composés hétérocycliques 3 noyaux", "url": "https://questionsmedicales.fr/mesh/D006575", "about": { "@type": "MedicalCondition", "name": "Composés hétérocycliques 3 noyaux", "code": { "@type": "MedicalCode", "code": "D006575", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.300" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Propanthéline", "alternateName": "Propantheline", "url": "https://questionsmedicales.fr/mesh/D011413", "about": { "@type": "MedicalCondition", "name": "Propanthéline", "code": { "@type": "MedicalCode", "code": "D011413", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.300.953.558" } } }, { "@type": "MedicalWebPage", "name": "Pyronine", "alternateName": "Pyronine", "url": "https://questionsmedicales.fr/mesh/D011754", "about": { "@type": "MedicalCondition", "name": "Pyronine", "code": { "@type": "MedicalCode", "code": "D011754", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.300.953.570" } } }, { "@type": "MedicalWebPage", "name": "Rhodamines", "alternateName": "Rhodamines", "url": "https://questionsmedicales.fr/mesh/D012235", "about": { "@type": "MedicalCondition", "name": "Rhodamines", "code": { "@type": "MedicalCode", "code": "D012235", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.300.953.600" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Rhodamine 123", "alternateName": "Rhodamine 123", "url": "https://questionsmedicales.fr/mesh/D020112", "about": { "@type": "MedicalCondition", "name": "Rhodamine 123", "code": { "@type": "MedicalCode", "code": "D020112", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.300.953.600.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Thioxanthènes", "alternateName": "Thioxanthenes", "url": "https://questionsmedicales.fr/mesh/D013892", "about": { "@type": "MedicalCondition", "name": "Thioxanthènes", "code": { "@type": "MedicalCode", "code": "D013892", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.300.953.704" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Chlorprothixène", "alternateName": "Chlorprothixene", "url": "https://questionsmedicales.fr/mesh/D002749", "about": { "@type": "MedicalCondition", "name": "Chlorprothixène", "code": { "@type": "MedicalCode", "code": "D002749", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.300.953.704.250" } } }, { "@type": "MedicalWebPage", "name": "Clopenthixol", "alternateName": "Clopenthixol", "url": "https://questionsmedicales.fr/mesh/D003006", "about": { "@type": "MedicalCondition", "name": "Clopenthixol", "code": { "@type": "MedicalCode", "code": "D003006", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.300.953.704.269" } } }, { "@type": "MedicalWebPage", "name": "Flupentixol", "alternateName": "Flupenthixol", "url": "https://questionsmedicales.fr/mesh/D005475", "about": { "@type": "MedicalCondition", "name": "Flupentixol", "code": { "@type": "MedicalCode", "code": "D005475", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.300.953.704.360" } } }, { "@type": "MedicalWebPage", "name": "Hycanthone", "alternateName": "Hycanthone", "url": "https://questionsmedicales.fr/mesh/D006826", "about": { "@type": "MedicalCondition", "name": "Hycanthone", "code": { "@type": "MedicalCode", "code": "D006826", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.300.953.704.450" } } }, { "@type": "MedicalWebPage", "name": "Tiotixène", "alternateName": "Thiothixene", "url": "https://questionsmedicales.fr/mesh/D013888", "about": { "@type": "MedicalCondition", "name": "Tiotixène", "code": { "@type": "MedicalCode", "code": "D013888", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.300.953.704.787" } } } ] }, { "@type": "MedicalWebPage", "name": "Xanthones", "alternateName": "Xanthones", "url": "https://questionsmedicales.fr/mesh/D044004", "about": { "@type": "MedicalCondition", "name": "Xanthones", "code": { "@type": "MedicalCode", "code": "D044004", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.300.953.852" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Lucanthone", "alternateName": "Lucanthone", "url": "https://questionsmedicales.fr/mesh/D008154", "about": { "@type": "MedicalCondition", "name": "Lucanthone", "code": { "@type": "MedicalCode", "code": "D008154", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.300.953.852.388" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Xanthènes", "alternateName": "Xanthenes", "code": { "@type": "MedicalCode", "code": "D014966", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Hongji Li", "url": "https://questionsmedicales.fr/author/Hongji%20Li", "affiliation": { "@type": "Organization", "name": "Key Laboratory of Green and Precise Synthetic Chemistry and Applications, Ministry of Education, School of Chemistry and Materials Science, Huaibei Normal University, Huaibei, Anhui 235000, P. R. China." } }, { "@type": "Person", "name": "Steven R Gwaltney", "url": "https://questionsmedicales.fr/author/Steven%20R%20Gwaltney", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, Mississippi State University, Mississippi State, Mississippi 39762, United States." } }, { "@type": "Person", "name": "Colleen N Scott", "url": "https://questionsmedicales.fr/author/Colleen%20N%20Scott", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, Mississippi State University, Mississippi State, Mississippi 39762, United States." } }, { "@type": "Person", "name": "Ramalingam Manivannan", "url": "https://questionsmedicales.fr/author/Ramalingam%20Manivannan", "affiliation": { "@type": "Organization", "name": "Department of Advanced Organic Materials Engineering, Chungnam National University, 220 Gung-dong, Yuseong-gu, Daejeon, 305-764, South Korea." } }, { "@type": "Person", "name": "Young-A Son", "url": "https://questionsmedicales.fr/author/Young-A%20Son", "affiliation": { "@type": "Organization", "name": "Department of Advanced Organic Materials Engineering, Chungnam National University, 220 Gung-dong, Yuseong-gu, Daejeon, 305-764, South Korea. yason@cnu.ac.kr." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "The Children of Risk Communication.", "datePublished": "2022-07-10", "url": "https://questionsmedicales.fr/article/35815538", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/14034948221110409" } }, { "@type": "ScholarlyArticle", "name": "Clinical Communication in Rehabilitation.", "datePublished": "2022-06-14", "url": "https://questionsmedicales.fr/article/35742516", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijerph19127268" } }, { "@type": "ScholarlyArticle", "name": "Essential Elements of Communication.", "datePublished": "2022-05-28", "url": "https://questionsmedicales.fr/article/35725223", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.mcna.2022.01.004" } }, { "@type": "ScholarlyArticle", "name": "The color communication game.", "datePublished": "2023-09-25", "url": "https://questionsmedicales.fr/article/37749107", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-023-42834-3" } }, { "@type": "ScholarlyArticle", "name": "Patients' preferences for fracture risk communication: the Risk Communication in Osteoporosis (RICO) study.", "datePublished": "2023-11-13", "url": "https://questionsmedicales.fr/article/37955683", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00198-023-06955-9" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés hétérocycliques", "item": "https://questionsmedicales.fr/mesh/D006571" }, { "@type": "ListItem", "position": 3, "name": "Composés hétérocycliques à cycles fusionnés", "item": "https://questionsmedicales.fr/mesh/D000072471" }, { "@type": "ListItem", "position": 4, "name": "Composés hétérocycliques 3 noyaux", "item": "https://questionsmedicales.fr/mesh/D006575" }, { "@type": "ListItem", "position": 5, "name": "Xanthènes", "item": "https://questionsmedicales.fr/mesh/D014966" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Xanthènes - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Xanthènes", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-13", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Xanthènes", "description": "Comment diagnostiquer une intoxication aux xanthènes ?\nQuels tests sont utilisés pour détecter les xanthènes ?\nQuels symptômes indiquent une exposition aux xanthènes ?\nLes xanthènes peuvent-ils être détectés dans l'urine ?\nQuel rôle joue l'historique médical dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D014966?mesh_terms=Communication&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Xanthènes", "description": "Quels sont les symptômes courants d'une exposition aux xanthènes ?\nLes xanthènes provoquent-ils des réactions allergiques ?\nComment les xanthènes affectent-ils le système nerveux ?\nLes symptômes varient-ils selon le type de xanthène ?\nLes xanthènes affectent-ils la peau ?", "url": "https://questionsmedicales.fr/mesh/D014966?mesh_terms=Communication&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Xanthènes", "description": "Comment prévenir l'exposition aux xanthènes ?\nLes travailleurs doivent-ils être formés sur les xanthènes ?\nQuelles mesures de sécurité doivent être prises en laboratoire ?\nLes xanthènes sont-ils réglementés ?\nComment informer le public sur les dangers des xanthènes ?", "url": "https://questionsmedicales.fr/mesh/D014966?mesh_terms=Communication&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Xanthènes", "description": "Quel traitement est recommandé en cas d'intoxication aux xanthènes ?\nDes antidotes existent-ils pour les xanthènes ?\nComment traiter les symptômes neurologiques causés par les xanthènes ?\nLes soins de soutien sont-ils nécessaires ?\nPeut-on utiliser des traitements naturels contre les xanthènes ?", "url": "https://questionsmedicales.fr/mesh/D014966?mesh_terms=Communication&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Xanthènes", "description": "Quelles complications peuvent survenir après une exposition aux xanthènes ?\nLes xanthènes peuvent-ils causer des maladies chroniques ?\nY a-t-il des effets à long terme des xanthènes ?\nLes xanthènes peuvent-ils affecter la reproduction ?\nComment gérer les complications liées aux xanthènes ?", "url": "https://questionsmedicales.fr/mesh/D014966?mesh_terms=Communication&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Xanthènes", "description": "Qui est le plus à risque d'exposition aux xanthènes ?\nLes enfants sont-ils plus vulnérables aux xanthènes ?\nQuels facteurs environnementaux augmentent le risque ?\nLes antécédents médicaux influencent-ils le risque ?\nLes habitudes de vie jouent-elles un rôle dans le risque ?", "url": "https://questionsmedicales.fr/mesh/D014966?mesh_terms=Communication&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une intoxication aux xanthènes ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'historique d'exposition et des tests sanguins spécifiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour détecter les xanthènes ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des analyses chromatographiques comme la HPLC sont couramment utilisées." } }, { "@type": "Question", "name": "Quels symptômes indiquent une exposition aux xanthènes ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des nausées, des vertiges et des troubles neurologiques." } }, { "@type": "Question", "name": "Les xanthènes peuvent-ils être détectés dans l'urine ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests urinaires peuvent révéler la présence de xanthènes." } }, { "@type": "Question", "name": "Quel rôle joue l'historique médical dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'historique aide à identifier les expositions antérieures aux xanthènes." } }, { "@type": "Question", "name": "Quels sont les symptômes courants d'une exposition aux xanthènes ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des maux de tête, des nausées et des troubles de la vision." } }, { "@type": "Question", "name": "Les xanthènes provoquent-ils des réactions allergiques ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines personnes peuvent développer des réactions allergiques aux xanthènes." } }, { "@type": "Question", "name": "Comment les xanthènes affectent-ils le système nerveux ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent provoquer des troubles neurologiques comme des convulsions ou des tremblements." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le type de xanthène ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier selon la structure chimique des xanthènes." } }, { "@type": "Question", "name": "Les xanthènes affectent-ils la peau ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une exposition cutanée peut entraîner des irritations ou des éruptions." } }, { "@type": "Question", "name": "Comment prévenir l'exposition aux xanthènes ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Évitez les produits contenant des xanthènes et portez des équipements de protection." } }, { "@type": "Question", "name": "Les travailleurs doivent-ils être formés sur les xanthènes ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une formation sur les risques et la manipulation sécurisée est essentielle." } }, { "@type": "Question", "name": "Quelles mesures de sécurité doivent être prises en laboratoire ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Utilisez des hottes, des gants et des lunettes de protection lors de la manipulation." } }, { "@type": "Question", "name": "Les xanthènes sont-ils réglementés ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, leur utilisation est souvent réglementée pour protéger la santé publique." } }, { "@type": "Question", "name": "Comment informer le public sur les dangers des xanthènes ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Des campagnes de sensibilisation et des brochures d'information peuvent être utiles." } }, { "@type": "Question", "name": "Quel traitement est recommandé en cas d'intoxication aux xanthènes ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement inclut l'élimination de l'exposition et des soins symptomatiques." } }, { "@type": "Question", "name": "Des antidotes existent-ils pour les xanthènes ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas d'antidote spécifique pour les xanthènes." } }, { "@type": "Question", "name": "Comment traiter les symptômes neurologiques causés par les xanthènes ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments anticonvulsivants peuvent être utilisés pour gérer les symptômes." } }, { "@type": "Question", "name": "Les soins de soutien sont-ils nécessaires ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des soins de soutien sont souvent nécessaires pour les cas graves." } }, { "@type": "Question", "name": "Peut-on utiliser des traitements naturels contre les xanthènes ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de preuves solides pour des traitements naturels efficaces." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après une exposition aux xanthènes ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications neurologiques et dermatologiques peuvent se développer." } }, { "@type": "Question", "name": "Les xanthènes peuvent-ils causer des maladies chroniques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Une exposition prolongée peut augmenter le risque de maladies chroniques." } }, { "@type": "Question", "name": "Y a-t-il des effets à long terme des xanthènes ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des effets à long terme incluent des troubles cognitifs et des problèmes de santé." } }, { "@type": "Question", "name": "Les xanthènes peuvent-ils affecter la reproduction ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines études suggèrent qu'ils peuvent avoir des effets néfastes sur la reproduction." } }, { "@type": "Question", "name": "Comment gérer les complications liées aux xanthènes ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi médical régulier et des traitements symptomatiques sont recommandés." } }, { "@type": "Question", "name": "Qui est le plus à risque d'exposition aux xanthènes ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les travailleurs dans l'industrie chimique et les laboratoires sont les plus à risque." } }, { "@type": "Question", "name": "Les enfants sont-ils plus vulnérables aux xanthènes ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants peuvent être plus sensibles aux effets toxiques des xanthènes." } }, { "@type": "Question", "name": "Quels facteurs environnementaux augmentent le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "La pollution et l'exposition à des produits chimiques augmentent le risque." } }, { "@type": "Question", "name": "Les antécédents médicaux influencent-ils le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de maladies respiratoires ou neurologiques augmentent le risque." } }, { "@type": "Question", "name": "Les habitudes de vie jouent-elles un rôle dans le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des habitudes comme le tabagisme peuvent augmenter la vulnérabilité aux xanthènes." } } ] } ] }

Sources (10000 au total)

Patients' preferences for fracture risk communication: the Risk Communication in Osteoporosis (RICO) study.

The RICO study indicated that most patients would like to receive information regarding their fracture risk but that only a small majority have actually received it. Patients globally preferred a visu... The aim of the Risk Communication in Osteoporosis (RICO) study was to assess patients' preferences regarding fracture risk communication.... To assess patients' preferences for fracture risk communication, structured interviews with women with osteoporosis or who were at risk for fracture were conducted in 11 sites around the world, namely... A total of 332 women (mean age 67.5 ± 8.0 years, 48% with a history of fracture) were included in the study. Although the participants considered it important to receive information about their fractu... There is a significant communication gap between healthcare professionals and patients when discussing osteoporosis fracture risk. The RICO study provides insight into preferred approaches to rectify ...

Communication partners experiences of communicating with adults with severe/profound intellectual disability through augmentative and alternative communication: A mixed methods systematic review.

People with severe/profound intellectual disability experience challenges in communicating and require their communication partners to adapt to their means of communication. Augmentative and Alternati...

Improving interprofessional communication: Conceptualizing, operationalizing and testing a healthcare improvisation communication workshop.

Communication errors are a leading cause of adverse events in the acute and ambulatory healthcare setting. We now understand that communication within and across professions and patients is a complex ... We report on the interdisciplinary conceptualization, operationalization, and effectiveness testing of a novel educational healthcare improvisation communication workshop.... Prospective pre-post test experimental.... University of California, Irvine.... Total of 158 nursing, medicine, and population health students.... We conceptualized improvisation through the constructs of presence, trust, and acceptance to develop workshop activities, then used the Kirkpatrick Learning Framework to test the workshop's feasibilit... Participants rated the feasibility of the workshop highly. Pre-post workshop effectiveness testing showed significant increases in communication and collaboration competencies. Qualitative data sugges... We have developed and tested a communication teaching modality with strong conceptual grounding and empirical evidence of its efficacy in engaging healthcare students in collaborative communication, w...

A Comparison of Voice Amplifiers and Personal Communication Systems for Hypophonia: An Exploration of Communicative Participation.

The primary purpose of this study was to evaluate how individuals with hypophonia (HP; also referred to as HP participants) and their primary communication partners (PCPs; also referred to as PCP part... Seventeen individuals with HP and their PCPs participated in a crossover design study that compared three different amplification devices: a wired belt-pack amplifier, a wireless stationary amplifier,... Overall, HP participants rated communicative participation following device use higher than that in the pre-device condition, with the FM system resulting in the overall highest VAPP ratings and secon... This study contributes to an increased understanding of how communicative participation is experienced within this clinical population resulting from speech amplification. It is suggested that the inc...

Measuring Communicative Congruence and Communicative Dysphoria in a Sample of Individuals Without Voice Disorders.

This study examines communicative congruence and communicative dysphoria in adults who deny having a voice disorder.... Participants (adults 18-70 years) completed the BFAS, CES-D, VCS, and the Voice Handicap Index-10 (VHI-10) before recording a series of speech tasks. Participants' recordings were played back while th... The 196 participants were predominantly female (67.3%) and cisgender (96.4%). Communicative congruence was negatively skewed, and communicative dysphoria was normally distributed. Both variables signi... Counter to our hypothesis, participants reported more congruence than incongruence, but all other hypotheses were supported. Participants who reported... https://doi.org/10.23641/asha.20739967....

Communication skills of medical students: Evaluation of a new communication curriculum at the University of Augsburg.

Teaching communication skills plays a pivotal role in medical curricula. The aim of this article is to describe and evaluate a new communication curriculum developed at the Faculty of Medicine, Univer... A total of 150 medical students enrolled in the 1... Overall, students reported improved communications skills due to attending the KomCuA and further considered practicing with simulated patients as being very helpful (large effect sizes). Compared to ... The KomCuA has shown to be an effective communication curriculum to support medical students in the development of their communication skills and positive attitudes towards empathy. Additional studies...